1.28
14.67%
-0.22
Dopo l'orario di chiusura:
1.24
-0.04
-3.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Trinity Biotech Plc Adr Borsa (TRIB) Ultime notizie
Balance Sheet Breakdown: Trinity Biotech Plc ADR (TRIB)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Trinity Biotech to launch CGM tech in India, seeks feedback - Investing.com
Trinity Biotech names new Chief Commercial Officer - Investing.com
Trinity Biotech names new Chief Commercial Officer - Investing.com India
It is Poised to be a Bull Market for Trinity Biotech Plc ADR (TRIB) - SETE News
Market Recap: Trinity Biotech Plc ADR (TRIB)’s financial ratios: A comprehensive overview - The Dwinnex
Examining Trinity Biotech Plc ADR (TRIB) stock is warranted - US Post News
Trinity Biotech Plc ADR (TRIB) is looking forward to a strong quarter - SETE News
A Tale of Resilience: Trinity Biotech Plc ADR Amid Stock Market Turbulence - The InvestChronicle
Ratios Reveal: Breaking Down Trinity Biotech Plc ADR (TRIB)’s Financial Health - The Dwinnex
Martin Shkreli ordered to give up all copies of one-of-a-kind Wu-Tang Clan album - CNN
Trinity Biotech raises 2024 sales forecast for HIV test - Investing.com India
Trinity Biotech raises 2024 sales forecast for HIV test - Investing.com
Li Auto Inc. Sponsored ADR (LI) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Trinity Biotech appoints new biosensor marketing director - Investing.com India
Trinity Biotech appoints new biosensor marketing director - Investing.com
Why PDD Holdings Inc. Sponsored ADR (PDD) Outpaced the Stock Market Today - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Laps the Stock Market: Here's Why - Yahoo Finance
Contrast Security Application Detection and Response (ADR) Praised by Industry Analysts for Addressing Gap in Cybersecurity Defenses - Yahoo Finance
Trinity Biotech gets extension to meet Nasdaq listing rules - Investing.com India
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Trinity Biotech projects Q2 revenue growth, UK deal - Investing.com
Biotech Stock Roundup: BMY, GSK, BIIB's Q2 Results, VTVT Down on Setback - Yahoo Finance
Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y - Yahoo Finance
Sea Limited Sponsored ADR (SE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid - Yahoo Finance
Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last? - Yahoo Finance
Is Bayerische Motoren Werke AG Sponsored ADR (BMWYY) Stock Undervalued Right Now? - Yahoo Finance
Trinity Biotech appoints new CFO - Investing.com India
Trinity Biotech appoints new CFO - Investing.com
Trinity Biotech appoints new CFO By Investing.com - Investing.com
Kintara Therapeutics restructures share designations By Investing.com - Investing.com
Trinity Biotech appoints new CFO By Investing.com - Investing.com India
Trinity Bio ADR (TRIB-Q) QuotePress Release - The Globe and Mail
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
XPeng Inc. Sponsored ADR (XPEV) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor - GlobeNewswire Inc.
Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association - GlobeNewswire Inc.
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates - Yahoo Finance
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology - GlobeNewswire Inc.
Why the Dow fell 1,000 points in the last three days - CNN
Earnings call: Trinity Biotech eyes growth with HIV test and CGM tech - Investing.com India
Earnings call: Trinity Biotech eyes growth with HIV test and CGM tech By Investing.com - Investing.com
Wall Street is about to see its biggest trading change in years - CNN
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance - GlobeNewswire Inc.
Trinity Biotech plc to Announce Q1 2024 Financial Results - GlobeNewswire Inc.
Is Bicycle Therapeutics (BCYC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Here's Why Vista Oil & Gas, S.A.B. de C.V. Sponsored ADR (VIST) Gained But Lagged the Market Today - Yahoo Finance
Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI - GlobeNewswire Inc.
Analysts Estimate Endava PLC Sponsored ADR (DAVA) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales - GlobeNewswire Inc.
Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development - GlobeNewswire Inc.
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More - Yahoo Finance
Fortescue Ltd. Sponsored ADR (FSUGY) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate - Yahoo Finance
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates - GlobeNewswire Inc.
New Strong Buy Stocks for April 4th - Yahoo Finance
Sea Limited Sponsored ADR (SE) Declines More Than Market: Some Information for Investors - Yahoo Finance
Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results - GlobeNewswire Inc.
11 Best ASX Stocks To Buy Now - Yahoo Finance
Here's Why Opera Limited Sponsored ADR (OPRA) Fell More Than Broader Market - Yahoo Finance
Stay Ahead of the Game With Sea Limited Sponsored ADR (SE) Q4 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
Recursion Pharmaceuticals (RXRX) Surges 13.8%: Is This an Indication of Further Gains? - Yahoo Finance
Sea Limited Sponsored ADR (SE) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
23andMe is low on cash and its stock is worth pennies. The CEO wants another chance - CNN
SELLAS (SLS) Rises on FDA Fast Track Tag to Leukemia Candidate - Yahoo Finance
Antonio De Rosa and ADR StudioA Legacy of Design and Innovation - Yahoo Finance
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):